Boston Medical Center
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Boston Medical Center
The data compares the sensitivity of almost 200 diagnostics against a standardized set of samples.
In tandem with Roivant, Cincinnati Children’s launches spinout Aruvant focused on hematologic disorders and separately teams with BridgeBio on genetic disease therapies. Roivant spinout Axovant licenses gene therapy candidates from University of Massachusetts.
The advanced wound care market is attracting an increasing number of competitors and investors seeking a stake in this high-need, high-growth space. But although the number of innovative wound care products is on the rise, this is also a highly diverse market, with some striking differences among various regions of the world in terms of product adoption and standard wound care practices.
If technology changes and clinical outcomes assert their influence over standard protocols, an increasing number of Americans patients will undergo coronary angioplasty through the radial artery in their wrist, not the femoral artery in their groin. As studies are beginning to portray more clearly, those patients are likely to be more comfortable postprocedure, exhibit less bleeding, and recover more quickly than patients treated treated with the traditional femoral approach.
- Academic and Research Institutions